Immunologists and vaccine experts say there's no valid reason to split the MMR vaccine into separate shots, as a new ...

President Donald Trump's repeated calls to "break up the MMR shot" and "take them separately" might have Americans wondering whether they can get separate shots and how and why the vaccines were ever ...

Antibodies are an important defense against SARS-CoV-2, but the virus continues to evolve ways to evade them. Now, researchers have mapped how antibodies target a key region of the virus's spike ...

Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with ...

President Trump is calling for immunizations for measles, mumps and rubella to be given in individual jabs in three different appointments instead of the standard combination shot.

President Trump's new executive order on vaccines raises a number of public health concerns. A physician breaks those down.

FDA Approval of Replimune's Intratumoral Therapy in Combination With Checkpoint Inhibition Reinforces Growing Momentum Behind ...

Stand Up To Cancer® (SU2C) today announced the recipients of the SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award. The approximately $225,000 in award funding will support a multi ...

Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027 ...

Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations and specifically calling for combination vaccines to be separated ...

Replimune Group, Inc. (Nasdaq: REPL) ('Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the pricing of an ...

Broad label to address high unmet need in advanced melanomaReplimune will host conference call on August 6, 2026 at 4:30 p.m. ET. WOBURN, ...